MENTHOL

MENTHOL was reported 50286 times

MENTHOL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 URTICARIA THERMAL 20 0.1408
1 THIRD DEGREE CHEMICAL BURN OF SKIN 3 0.0714
2 NAIL BED TENDERNESS 8 0.0702
3 CHEMICAL INJURY 47 0.0575
4 ADMINISTRATION SITE ERYTHEMA 14 0.0491
5 VICTIM OF SPOUSAL ABUSE 3 0.0469
6 CHEMICAL BURN 50 0.0434
7 BURNS FIRST DEGREE 11 0.0386
8 COLONIC HAEMATOMA 3 0.0353
9 BURNS SECOND DEGREE 57 0.0325
10 APPLICATION SITE BURN 150 0.0304
11 EPITHELIOID MESOTHELIOMA 10 0.0285
12 BURNS THIRD DEGREE 23 0.0218
13 BURN INFECTION 4 0.0196
14 PERITONEAL MESOTHELIOMA MALIGNANT 3 0.0155
15 CARDIOACTIVE DRUG LEVEL DECREASED 2 0.0117
16 PLEURAL MESOTHELIOMA MALIGNANT 3 0.0097
17 ADULT FAILURE TO THRIVE 2 0.0094
18 THERMAL BURN 64 0.0090
19 OVERLAP SYNDROME 6 0.0086
20 APPLICATION SITE HYPOAESTHESIA 2 0.0085
21 DEVICE MAINTENANCE ISSUE 5 0.0085
22 ACCELERATED HYPERTENSION 3 0.0079
23 AUTONOMIC NEUROPATHY 8 0.0079
24 DENTURE WEARER 2 0.0077
25 C-REACTIVE PROTEIN 7 0.0076
26 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 8 0.0075
27 APPLICATION SITE VESICLES 45 0.0069
28 APPLICATION SITE SCAR 8 0.0064
29 LUPUS VULGARIS 8 0.0063
30 BACTERIAL TRANSLOCATION 2 0.0063
31 CHEMICAL BURN OF SKIN 15 0.0059
32 CHRONIC RESPIRATORY DISEASE 2 0.0057
33 APPLICATION SITE WARMTH 7 0.0055
34 MESOTHELIOMA 7 0.0054
35 APPLICATION SITE PAIN 116 0.0053
36 VITAMIN B12 DEFICIENCY 21 0.0052
37 CEREBRAL ARTERIOSCLEROSIS 2 0.0052
38 ANTICHOLINERGIC SYNDROME 8 0.0050
39 HYPERPARATHYROIDISM SECONDARY 12 0.0048
40 EXPOSURE TO CHEMICAL POLLUTION 8 0.0047
41 BONE SCAN ABNORMAL 2 0.0047
42 HYPERCHOLESTEROLAEMIA 44 0.0046
43 DEEP VEIN THROMBOSIS POSTOPERATIVE 9 0.0045
44 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 3 0.0045
45 DOPAMINE DYSREGULATION SYNDROME 2 0.0045
46 ALLERGY TO PLANTS 2 0.0044
47 RETINAL PIGMENT EPITHELIAL TEAR 3 0.0043
48 INFUSION SITE INFLAMMATION 3 0.0042
49 APPLICATION SITE BRUISE 4 0.0041
50 APPLICATION SITE INFECTION 2 0.0039
51 APPLICATION SITE DISCOMFORT 7 0.0039
52 BLOOD GASES ABNORMAL 2 0.0037
53 POST-TRAUMATIC NECK SYNDROME 3 0.0037
54 RETINITIS 6 0.0035
55 ADMINISTRATION SITE PAIN 4 0.0035
56 DEEP BRAIN STIMULATION 2 0.0033
57 JOINT DISLOCATION 35 0.0033
58 VULVOVAGINAL SWELLING 6 0.0033
59 PIGMENTATION DISORDER 20 0.0032
60 URINARY TRACT INFECTION ENTEROCOCCAL 3 0.0032
61 BLOOD CHLORIDE DECREASED 8 0.0031
62 SKIN OEDEMA 3 0.0030
63 APPLICATION SITE INFLAMMATION 4 0.0029
64 RESPIRATORY TRACT IRRITATION 3 0.0029
65 INFUSION SITE DISCHARGE 5 0.0028
66 DERMATITIS DIAPER 2 0.0028
67 SWOLLEN JOINT COUNT INCREASED 9 0.0028
68 NEUROMYOPATHY 3 0.0028
69 NEPHROGENIC ANAEMIA 13 0.0028
70 TRAUMATIC HAEMATOMA 3 0.0028
71 BLADDER TRANSITIONAL CELL CARCINOMA 4 0.0028
72 APPLICATION SITE ERYTHEMA 73 0.0028
73 APPLICATION SITE SCAB 6 0.0028
74 LABYRINTHITIS 7 0.0028
75 OBSTRUCTIVE SLEEP APNOEA SYNDROME 4 0.0027
76 RHEUMATIC FEVER 12 0.0027
77 AMPHETAMINES POSITIVE 2 0.0027
78 CLONUS 7 0.0026
79 INFUSION SITE WARMTH 3 0.0024
80 INFUSION SITE HAEMORRHAGE 8 0.0024
81 APPLICATION SITE EXFOLIATION 10 0.0024
82 APPLICATION SITE SWELLING 12 0.0024
83 DERMATITIS EXFOLIATIVE 12 0.0024
84 SCAR 41 0.0024
85 SKIN PLAQUE 20 0.0024
86 INFUSION SITE IRRITATION 3 0.0023
87 SECRETION DISCHARGE 29 0.0023
88 BLOOD ALKALINE PHOSPHATASE ABNORMAL 2 0.0022
89 APPLICATION SITE DISCOLOURATION 9 0.0022
90 SKIN DEPIGMENTATION 3 0.0022
91 ESSENTIAL HYPERTENSION 4 0.0022
92 RHONCHI 3 0.0022
93 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 2 0.0022
94 ACTINOMYCOSIS 2 0.0021
95 SCRATCH 22 0.0021
96 COMA SCALE ABNORMAL 6 0.0021
97 DIZZINESS POSTURAL 20 0.0021
98 HELICOBACTER INFECTION 21 0.0020
99 INFUSION SITE INDURATION 3 0.0020
100 JOINT RANGE OF MOTION DECREASED 27 0.0020
101 BONE EROSION 7 0.0020
102 HIP ARTHROPLASTY 30 0.0020
103 SKIN ABRASION 9 0.0019
104 INFUSION SITE PRURITUS 6 0.0019
105 NASAL ULCER 3 0.0019
106 INFUSION SITE BRUISING 4 0.0019
107 PLEURITIC PAIN 5 0.0018
108 TEMPERATURE REGULATION DISORDER 4 0.0018
109 BLISTER 99 0.0018
110 DUODENAL ULCER PERFORATION 13 0.0017
111 RHEUMATOID FACTOR POSITIVE 10 0.0017
112 IRRITABLE BOWEL SYNDROME 36 0.0017
113 APPLICATION SITE HYPERSENSITIVITY 2 0.0016
114 RECTAL CANCER 5 0.0016
115 SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS 3 0.0016
116 JAUNDICE NEONATAL 3 0.0016
117 MYELOPATHY 3 0.0016
118 SCAB 18 0.0016
119 MUSCLE INJURY 13 0.0016
120 OROPHARYNGEAL DISCOMFORT 14 0.0015
121 INFUSION SITE ERYTHEMA 13 0.0015
122 AUTOIMMUNE DISORDER 15 0.0015
123 HYPOVOLAEMIA 9 0.0015
124 ADRENOCORTICAL INSUFFICIENCY ACUTE 3 0.0015
125 WOUND SECRETION 6 0.0015
126 PERSONALITY DISORDER 4 0.0015
127 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 3 0.0015
128 CHONDROPATHY 4 0.0015
129 INFUSION SITE PAIN 19 0.0015
130 ABSCESS ORAL 2 0.0015
131 QUADRIPLEGIA 3 0.0015
132 INFUSION SITE SWELLING 9 0.0014
133 SEASONAL ALLERGY 20 0.0014
134 MULTIPLE ALLERGIES 11 0.0014
135 C-REACTIVE PROTEIN ABNORMAL 9 0.0014
136 CATHETER SITE ERYTHEMA 3 0.0014
137 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 10 0.0014
138 LIMB MASS 3 0.0014
139 ELECTROCARDIOGRAM T WAVE INVERSION 3 0.0014
140 GASTROINTESTINAL ULCER 3 0.0014
141 ATYPICAL PNEUMONIA 4 0.0013
142 JOINT STIFFNESS 35 0.0013
143 KNEE ARTHROPLASTY 28 0.0013
144 LIP DRY 12 0.0013
145 HAEMATOCRIT INCREASED 3 0.0013
146 DISLOCATION OF VERTEBRA 3 0.0013
147 PARANASAL SINUS HYPERSECRETION 5 0.0013
148 IMPAIRED HEALING 43 0.0013
149 FIBROSIS 4 0.0013
150 NECK SURGERY 3 0.0013
151 ERYTHEMA MULTIFORME 12 0.0013
152 PRE-EXISTING CONDITION IMPROVED 8 0.0013
153 RESPIRATORY RATE DECREASED 4 0.0013
154 PNEUMONIA VIRAL 4 0.0013
155 SCIATICA 20 0.0013
156 STUPOR 4 0.0012
157 INTERNATIONAL NORMALISED RATIO DECREASED 5 0.0012
158 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 8 0.0012
159 BREATH ODOUR 3 0.0012
160 COSTOCHONDRITIS 2 0.0012
161 HYPERVOLAEMIA 6 0.0012
162 DEVICE INFUSION ISSUE 3 0.0012
163 LIVE BIRTH 10 0.0012
164 FIBROMYALGIA 29 0.0012
165 BURNING SENSATION 83 0.0012
166 APPLICATION SITE DRYNESS 4 0.0012
167 NERVE INJURY 13 0.0012
168 ACUTE SINUSITIS 2 0.0012
169 NO ADVERSE EVENT 209 0.0012
170 APPLICATION SITE REACTION 8 0.0011
171 GINGIVAL SWELLING 5 0.0011
172 AREFLEXIA 3 0.0011
173 EXOSTOSIS 10 0.0011
174 CHRONIC SINUSITIS 4 0.0011
175 WALKING AID USER 7 0.0011
176 NECK MASS 3 0.0011
177 HYPERTONIA 6 0.0010
178 HYPERTONIC BLADDER 3 0.0010
179 ULCER HAEMORRHAGE 7 0.0010
180 PRESCRIBED OVERDOSE 20 0.0010
181 RHINOVIRUS INFECTION 4 0.0010
182 PULMONARY PAIN 3 0.0010
183 LUMBAR SPINAL STENOSIS 3 0.0010
184 NECK INJURY 3 0.0010
185 COLOSTOMY 2 0.0010
186 RESPIRATORY RATE INCREASED 9 0.0010
187 SKIN BURNING SENSATION 72 0.0010
188 INFUSION SITE REACTION 3 0.0010
189 REBOUND ACID HYPERSECRETION 3 0.0010
190 LIP SWELLING 33 0.0010
191 DECUBITUS ULCER 8 0.0010
192 BRONCHOSPASM 14 0.0010
193 HYPERAESTHESIA 8 0.0010
194 DERMATITIS BULLOUS 7 0.0010
195 AKINESIA 2 0.0010
196 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 2 0.0010
197 FOETAL DEATH 5 0.0010
198 BLOOD BLISTER 3 0.0010
199 FOLLICULITIS 10 0.0010
200 IRIDOCYCLITIS 3 0.0009
201 INTESTINAL STENOSIS 4 0.0009
202 END STAGE RENAL DISEASE 17 0.0009
203 SKIN EROSION 3 0.0009
204 MUSCLE STRAIN 8 0.0009
205 FACET JOINT SYNDROME 3 0.0009
206 DIABETIC NEPHROPATHY 2 0.0009
207 CLOSTRIDIUM TEST POSITIVE 2 0.0009
208 C-REACTIVE PROTEIN INCREASED 33 0.0009
209 LIGAMENT RUPTURE 4 0.0009
210 SKIN INJURY 3 0.0009
211 NEPHRITIS 3 0.0009
212 BACTERIAL TEST POSITIVE 2 0.0009
213 PRODUCT ADMINISTRATION INTERRUPTED 7 0.0009
214 BLOOD CALCIUM DECREASED 10 0.0009
215 LUPUS-LIKE SYNDROME 8 0.0009
216 THERAPEUTIC PRODUCT EFFECT DELAYED 4 0.0009
217 HAEMOGLOBIN INCREASED 4 0.0009
218 DERMATITIS CONTACT 10 0.0009
219 GASTRITIS EROSIVE 4 0.0009
220 INSURANCE ISSUE 13 0.0008
221 GLOSSITIS 3 0.0008
222 RASH VESICULAR 4 0.0008
223 BURSITIS 10 0.0008
224 FOOT DEFORMITY 9 0.0008
225 CARTILAGE INJURY 2 0.0008
226 NEURODERMATITIS 3 0.0008
227 APPLICATION SITE IRRITATION 10 0.0008
228 PEMPHIGUS 10 0.0008
229 CATHETER SITE HAEMORRHAGE 2 0.0008
230 PEMPHIGOID 6 0.0008
231 DRY THROAT 8 0.0008
232 SKIN DISCOLOURATION 36 0.0008
233 INTERVERTEBRAL DISC PROTRUSION 17 0.0008
234 FOOD ALLERGY 6 0.0008
235 VARICOSE VEIN 4 0.0008
236 HAEMATOMA 20 0.0008
237 SPINAL CORD COMPRESSION 3 0.0008
238 INFUSION RELATED REACTION 51 0.0008
239 ORAL INFECTION 3 0.0008
240 HAND DEFORMITY 10 0.0008
241 GLOSSODYNIA 17 0.0008
242 HALLUCINATION, VISUAL 16 0.0008
243 OSTEOARTHRITIS 32 0.0008
244 BLOOD CHOLESTEROL INCREASED 35 0.0008
245 ANIMAL BITE 2 0.0007
246 DEFORMITY 7 0.0007
247 MUSCLE HAEMORRHAGE 3 0.0007
248 TYPE 2 DIABETES MELLITUS 25 0.0007
249 INJURY 52 0.0007
250 BACK INJURY 8 0.0007
251 HYPERKERATOSIS 4 0.0007
252 SYNOVITIS 13 0.0007
253 WOUND 20 0.0007
254 PHARYNGEAL SWELLING 7 0.0007
255 THERAPEUTIC PRODUCT EFFECT DECREASED 32 0.0007
256 PERICARDITIS 12 0.0007
257 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 13 0.0007
258 SHOULDER OPERATION 3 0.0007
259 TEARFULNESS 3 0.0007
260 SINUSITIS 71 0.0007
261 LIVER INJURY 17 0.0007
262 PRODUCT LABEL CONFUSION 4 0.0007
263 DEVICE POWER SOURCE ISSUE 2 0.0007
264 AUTONOMIC NERVOUS SYSTEM IMBALANCE 2 0.0007
265 NASAL CONGESTION 40 0.0007
266 PULMONARY FIBROSIS 13 0.0007
267 LOWER LIMB FRACTURE 13 0.0007
268 LOWER GASTROINTESTINAL HAEMORRHAGE 5 0.0007
269 BACTERAEMIA 8 0.0007
270 INCONTINENCE 7 0.0007
271 SINUS DISORDER 13 0.0007
272 LUMBAR VERTEBRAL FRACTURE 3 0.0007
273 APPLICATION SITE RASH 9 0.0007
274 SYNOVIAL CYST 3 0.0006
275 BRAIN NATRIURETIC PEPTIDE INCREASED 2 0.0006
276 NECK PAIN 36 0.0006
277 NEPHROPATHY 6 0.0006
278 NASAL DRYNESS 4 0.0006
279 MULTIPLE INJURIES 4 0.0006
280 ABDOMINAL ADHESIONS 2 0.0006
281 DRUG SCREEN POSITIVE 5 0.0006
282 RED BLOOD CELL SEDIMENTATION RATE INCREASED 7 0.0006
283 RIB FRACTURE 13 0.0006
284 ERYTHEMA 129 0.0006
285 ATELECTASIS 6 0.0006
286 INCOHERENT 4 0.0006
287 APPLICATION SITE PRURITUS 14 0.0006
288 SKIN EXFOLIATION 52 0.0006
289 INCORRECT DOSAGE ADMINISTERED 3 0.0006
290 NERVOUSNESS 32 0.0006
291 COELIAC DISEASE 6 0.0006
292 DISABILITY 12 0.0006
293 PRODUCT FORMULATION ISSUE 4 0.0006
294 EXPIRED DRUG ADMINISTERED 3 0.0006
295 PRESCRIBED UNDERDOSE 12 0.0006
296 BLOOD POTASSIUM DECREASED 18 0.0006
297 TERMINAL STATE 4 0.0006
298 ERYSIPELAS 3 0.0006
299 HYPOTHERMIA 6 0.0006
300 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 4 0.0006
301 TUBULOINTERSTITIAL NEPHRITIS 11 0.0006
302 ABNORMAL LOSS OF WEIGHT 4 0.0006
303 ACCIDENT 7 0.0006
304 ENDOCARDITIS 3 0.0006
305 OROPHARYNGEAL PAIN 54 0.0006
306 CONTUSION 56 0.0006
307 ONYCHOCLASIS 4 0.0006
308 INFECTION 84 0.0006
309 THERAPY NON-RESPONDER 26 0.0006
310 BLOOD CREATININE ABNORMAL 2 0.0006
311 TENDERNESS 6 0.0006
312 RESPIRATORY SYNCYTIAL VIRUS INFECTION 5 0.0006
313 SEDATION 15 0.0006
314 EXPIRED PRODUCT ADMINISTERED 19 0.0006
315 BRONCHIOLITIS 2 0.0006
316 GRIP STRENGTH DECREASED 5 0.0006
317 NIGHT SWEATS 18 0.0006
318 GINGIVITIS 3 0.0006
319 BACK PAIN 129 0.0006
320 CHRONIC KIDNEY DISEASE 42 0.0006
321 HYDROCEPHALUS 3 0.0006
322 WOUND INFECTION 6 0.0005
323 BLOOD PHOSPHORUS DECREASED 2 0.0005
324 PHOTOSENSITIVITY REACTION 9 0.0005
325 CHOKING SENSATION 3 0.0005
326 FEELING DRUNK 4 0.0005
327 PERSONALITY CHANGE 5 0.0005
328 GASTRITIS 14 0.0005
329 NEUROLOGICAL SYMPTOM 3 0.0005
330 COMMUNICATION DISORDER 2 0.0005
331 MUSCULOSKELETAL DISCOMFORT 9 0.0005
332 DYSURIA 19 0.0005
333 SKIN WARM 3 0.0005
334 EAR PAIN 10 0.0005
335 APNOEA 4 0.0005
336 BLOOD PRESSURE SYSTOLIC INCREASED 10 0.0005
337 RHINORRHOEA 33 0.0005
338 DECREASED IMMUNE RESPONSIVENESS 5 0.0005
339 GLUCOSE TOLERANCE IMPAIRED 3 0.0005
340 BLOOD IRON DECREASED 6 0.0005
341 APHONIA 7 0.0005
342 HYPOAESTHESIA 75 0.0005
343 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 26 0.0005
344 SENSORY LOSS 4 0.0005
345 HYPERSENSITIVITY 92 0.0005
346 MUSCLE DISORDER 4 0.0005
347 MUSCLE TIGHTNESS 8 0.0005
348 INGUINAL HERNIA 3 0.0005
349 FEEDING DISORDER 10 0.0005
350 HEPATIC ENZYME INCREASED 33 0.0005
351 LOWER RESPIRATORY TRACT INFECTION 22 0.0005
352 COMPLICATION ASSOCIATED WITH DEVICE 7 0.0005
353 PRODUCTIVE COUGH 23 0.0005
354 SWELLING 45 0.0005
355 DRY MOUTH 39 0.0005
356 CONGESTIVE CARDIOMYOPATHY 2 0.0005
357 GAIT INABILITY 16 0.0005
358 LIMB INJURY 13 0.0005
359 URTICARIA 80 0.0005
360 UPPER RESPIRATORY TRACT INFECTION 22 0.0005
361 COUGH 132 0.0005
362 PULMONARY MASS 7 0.0005
363 ABSCESS LIMB 2 0.0005
364 CONTRAINDICATED PRODUCT ADMINISTERED 14 0.0005
365 ATRIOVENTRICULAR BLOCK FIRST DEGREE 2 0.0005
366 HAEMORRHOIDS 9 0.0005
367 DRUG ADMINISTRATION ERROR 14 0.0005
368 SPINAL OSTEOARTHRITIS 4 0.0005
369 LOCALISED INFECTION 11 0.0005
370 TUMOUR LYSIS SYNDROME 4 0.0005
371 LIMB DISCOMFORT 14 0.0005
372 MUSCULOSKELETAL CHEST PAIN 7 0.0005
373 TENDONITIS 7 0.0005
374 EAR INFECTION 12 0.0005
375 RASH MACULO-PAPULAR 10 0.0004
376 SKIN MASS 3 0.0004
377 POST-TRAUMATIC STRESS DISORDER 3 0.0004
378 PAIN 274 0.0004
379 MYOSITIS 4 0.0004
380 PAIN OF SKIN 12 0.0004
381 MOBILITY DECREASED 32 0.0004
382 OCULAR DISCOMFORT 5 0.0004
383 DRUG INTOLERANCE 43 0.0004
384 SINUS CONGESTION 6 0.0004
385 WRONG PRODUCT ADMINISTERED 3 0.0004
386 HEAD INJURY 14 0.0004
387 PRODUCT LABEL ISSUE 3 0.0004
388 TOOTHACHE 8 0.0004
389 RESTLESS LEGS SYNDROME 8 0.0004
390 NASOPHARYNGITIS 81 0.0004
391 MUSCULOSKELETAL PAIN 23 0.0004
392 ECCHYMOSIS 3 0.0004
393 SEPTIC SHOCK 19 0.0004
394 MUSCLE TWITCHING 10 0.0004
395 NERVE COMPRESSION 4 0.0004
396 ARTHRITIS INFECTIVE 2 0.0004
397 HYPERTENSION 91 0.0004
398 DEVICE OCCLUSION 6 0.0004
399 HYPONATRAEMIA 24 0.0004
400 HEPATIC CIRRHOSIS 8 0.0004
401 ARTERIOSCLEROSIS 4 0.0004
402 HALLUCINATION 32 0.0004
403 MUSCULOSKELETAL STIFFNESS 37 0.0004
404 IMPAIRED WORK ABILITY 9 0.0004
405 LIVER FUNCTION TEST ABNORMAL 12 0.0004
406 NEURALGIA 10 0.0004
407 CHOKING 8 0.0004
408 DISCOMFORT 25 0.0004
409 OXYGEN SATURATION DECREASED 23 0.0004
410 ILLNESS 42 0.0004
411 SENSITIVE SKIN 3 0.0004
412 SMALL INTESTINAL OBSTRUCTION 5 0.0004
413 DRUG EFFECT LESS THAN EXPECTED 6 0.0004
414 SKIN HAEMORRHAGE 6 0.0004
415 WHEEZING 24 0.0004
416 ABDOMINAL TENDERNESS 2 0.0004
417 IMMUNODEFICIENCY 6 0.0004
418 ILEUS 5 0.0004
419 LOCAL SWELLING 7 0.0004
420 CHILLS 47 0.0004
421 SALIVARY HYPERSECRETION 4 0.0004
422 DIABETES MELLITUS INADEQUATE CONTROL 7 0.0004
423 SYSTEMIC LUPUS ERYTHEMATOSUS 14 0.0004
424 TOOTH ABSCESS 4 0.0004
425 PRODUCT ADHESION ISSUE 14 0.0004
426 PRURITUS 150 0.0004
427 GOUT 7 0.0004
428 EAR DISCOMFORT 4 0.0004
429 ASTHMA 44 0.0004
430 INTENTIONAL PRODUCT USE ISSUE 34 0.0004
431 LUNG DISORDER 19 0.0004
432 ABDOMINAL DISCOMFORT 65 0.0004
433 BENIGN PROSTATIC HYPERPLASIA 2 0.0004
434 LEUKOCYTOSIS 7 0.0004
435 POOR VENOUS ACCESS 4 0.0004
436 NICOTINE DEPENDENCE 3 0.0004
437 INFLUENZA 43 0.0004
438 DEVICE INFORMATION OUTPUT ISSUE 3 0.0004
439 THERAPY PARTIAL RESPONDER 6 0.0004
440 RESPIRATORY TRACT INFECTION 10 0.0004
441 BRAIN FOG 6 0.0004
442 PRODUCT ODOUR ABNORMAL 4 0.0004
443 BLOOD LACTIC ACID INCREASED 2 0.0004
444 DRUG ADMINISTERED AT INAPPROPRIATE SITE 4 0.0004
445 MIGRAINE 36 0.0004
446 OBSESSIVE-COMPULSIVE DISORDER 3 0.0004
447 FLUID RETENTION 19 0.0004
448 COMPRESSION FRACTURE 2 0.0004
449 RECTAL HAEMORRHAGE 16 0.0004
450 ANAL ABSCESS 2 0.0004
451 BRUXISM 2 0.0004
452 CHEILITIS 2 0.0004
453 POST PROCEDURAL INFECTION 3 0.0004
454 ARTHRITIS 29 0.0004
455 INFLAMMATION 19 0.0004
456 SKIN LACERATION 4 0.0004
457 PAIN IN EXTREMITY 108 0.0004
458 GINGIVAL BLEEDING 5 0.0004
459 HICCUPS 3 0.0004
460 BRONCHITIS 27 0.0004
461 CORONARY ARTERY OCCLUSION 5 0.0004
462 POST PROCEDURAL COMPLICATION 7 0.0004
463 UPPER-AIRWAY COUGH SYNDROME 3 0.0004
464 PERIPHERAL SWELLING 56 0.0004
465 SPINAL COMPRESSION FRACTURE 3 0.0004
466 TOOTH FRACTURE 4 0.0004
467 DENTAL CARIES 4 0.0004
468 EMBOLISM 3 0.0004
469 MENTAL STATUS CHANGES 10 0.0004
470 ARTHROPATHY 20 0.0004
471 ORAL DISCOMFORT 5 0.0004
472 MYALGIA 61 0.0004
473 ROAD TRAFFIC ACCIDENT 15 0.0004
474 MALNUTRITION 4 0.0004
475 ORAL PAIN 8 0.0004
476 FISTULA 4 0.0004
477 SLEEP DISORDER 25 0.0004
478 MULTIPLE ORGAN DYSFUNCTION SYNDROME 10 0.0004
479 PAIN IN JAW 10 0.0004
480 CIRCULATORY COLLAPSE 6 0.0004
481 SWOLLEN TONGUE 11 0.0004
482 IMPAIRED DRIVING ABILITY 4 0.0004
483 CHOLECYSTECTOMY 4 0.0003
484 TREATMENT FAILURE 29 0.0003
485 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 6 0.0003
486 SKIN IRRITATION 16 0.0003
487 GASTROOESOPHAGEAL REFLUX DISEASE 28 0.0003
488 BLOOD URIC ACID INCREASED 2 0.0003
489 ANOSMIA 5 0.0003
490 ORTHOSTATIC HYPOTENSION 6 0.0003
491 DECREASED APPETITE 80 0.0003
492 RASH MACULAR 12 0.0003
493 OSTEOPOROSIS 14 0.0003
494 ACUTE KIDNEY INJURY 52 0.0003
495 FALL 113 0.0003
496 DRUG ERUPTION 6 0.0003
497 ATAXIA 4 0.0003
498 CATARACT OPERATION 2 0.0003
499 DRUG INEFFECTIVE 443 0.0003
500 FLATULENCE 19 0.0003
501 GASTROINTESTINAL INFECTION 3 0.0003
502 THROAT IRRITATION 15 0.0003
503 ANAL INCONTINENCE 3 0.0003
504 OEDEMA 18 0.0003
505 HYPOAESTHESIA ORAL 5 0.0003
506 STOMATITIS 20 0.0003
507 NOCTURIA 4 0.0003
508 ARTHRALGIA 137 0.0003
509 DERMATITIS ACNEIFORM 2 0.0003
510 RETCHING 7 0.0003
511 URINARY TRACT INFECTION 56 0.0003
512 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 18 0.0003
513 FEELING HOT 20 0.0003
514 IRON DEFICIENCY ANAEMIA 3 0.0003
515 FEMUR FRACTURE 10 0.0003
516 CONFUSIONAL STATE 52 0.0003
517 EJECTION FRACTION DECREASED 5 0.0003
518 PSORIATIC ARTHROPATHY 13 0.0003
519 PNEUMONIA ASPIRATION 8 0.0003
520 INCORRECT DRUG ADMINISTRATION DURATION 9 0.0003
521 INSOMNIA 85 0.0003
522 HYPOTENSION 64 0.0003
523 DERMATITIS ALLERGIC 4 0.0003
524 BLEPHAROSPASM 2 0.0003
525 CELLULITIS 16 0.0003
526 PRODUCT USE COMPLAINT 5 0.0003
527 FRACTURE 6 0.0003
528 SPINAL DISORDER 3 0.0003
529 MUSCULAR WEAKNESS 36 0.0003
530 FEBRILE NEUTROPENIA 21 0.0003
531 FOOT FRACTURE 6 0.0003
532 SLEEP APNOEA SYNDROME 6 0.0003
533 RASH ERYTHEMATOUS 15 0.0003
534 RASH PRURITIC 17 0.0003
535 ABSCESS 5 0.0003
536 HEART RATE INCREASED 31 0.0003
537 SEROTONIN SYNDROME 6 0.0003
538 HIATUS HERNIA 4 0.0003
539 BREAST CANCER STAGE III 2 0.0003
540 SOMNOLENCE 62 0.0003
541 DYSPNOEA 174 0.0003
542 JOINT SWELLING 37 0.0003
543 NODULE 4 0.0003
544 PNEUMONIA 99 0.0003
545 ACUTE MYOCARDIAL INFARCTION 9 0.0003
546 VITREOUS FLOATERS 3 0.0003
547 BODY TEMPERATURE DECREASED 3 0.0003
548 METASTASES TO BONE 5 0.0003
549 HOSPICE CARE 3 0.0003
550 LIGAMENT SPRAIN 3 0.0003
551 HYPOKALAEMIA 14 0.0003
552 SARS-COV-2 TEST POSITIVE 4 0.0003
553 CHEST PAIN 56 0.0003
554 INABILITY TO AFFORD MEDICATION 3 0.0003
555 BLOOD PRESSURE ABNORMAL 6 0.0003
556 INJECTION SITE BRUISING 24 0.0003
557 COAGULOPATHY 5 0.0003
558 FUNGAL INFECTION 10 0.0003
559 PREGNANCY 6 0.0003
560 CYTOKINE RELEASE SYNDROME 6 0.0003
561 BREAST MASS 2 0.0003
562 FULL BLOOD COUNT DECREASED 6 0.0003
563 PRODUCT PHYSICAL ISSUE 6 0.0003
564 THERAPEUTIC RESPONSE DECREASED 18 0.0003
565 FACE OEDEMA 5 0.0003
566 LETHARGY 17 0.0003
567 MOTOR DYSFUNCTION 3 0.0003
568 RENAL FAILURE 39 0.0003
569 ADVERSE EVENT 27 0.0003
570 INITIAL INSOMNIA 3 0.0003
571 SWELLING FACE 19 0.0003
572 DYSPHONIA 17 0.0003
573 RESPIRATORY DISTRESS 8 0.0003
574 HYPERBILIRUBINAEMIA 3 0.0003
575 ANAPHYLACTIC REACTION 16 0.0003
576 FEELING COLD 8 0.0003
577 HYPOMAGNESAEMIA 4 0.0003
578 INTENTIONAL DRUG MISUSE 6 0.0003
579 HAEMOPTYSIS 8 0.0003
580 WEIGHT FLUCTUATION 3 0.0003
581 MASS 4 0.0003
582 NEUROPATHY PERIPHERAL 27 0.0003
583 NEPHROLITHIASIS 13 0.0003
584 CLOSTRIDIUM DIFFICILE COLITIS 3 0.0003
585 BLOOD ALKALINE PHOSPHATASE INCREASED 7 0.0003
586 AGEUSIA 7 0.0003
587 HIP FRACTURE 9 0.0003
588 LIVER FUNCTION TEST INCREASED 6 0.0003
589 SEPSIS 31 0.0003
590 DISORIENTATION 11 0.0003
591 PRODUCT USE ISSUE 52 0.0003
592 DIZZINESS 138 0.0003
593 OSTEOMYELITIS 5 0.0003
594 PULMONARY THROMBOSIS 3 0.0003
595 HEADACHE 172 0.0003
596 ASPIRATION 3 0.0003
597 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 8 0.0003
598 GASTROINTESTINAL PAIN 3 0.0003
599 OEDEMA PERIPHERAL 33 0.0003
600 SKIN DISORDER 9 0.0003
601 TOOTH DISORDER 6 0.0003
602 THERAPEUTIC RESPONSE UNEXPECTED 12 0.0003
603 SKIN INFECTION 3 0.0003
604 INTESTINAL PERFORATION 3 0.0003
605 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 19 0.0003
606 CHROMATURIA 6 0.0003
607 DYSPNOEA EXERTIONAL 10 0.0003
608 PRODUCT QUALITY ISSUE 36 0.0003
609 APHASIA 8 0.0003
610 DEPRESSED MOOD 14 0.0003
611 HYPOCALCAEMIA 5 0.0003
612 ECONOMIC PROBLEM 4 0.0003
613 CHEST DISCOMFORT 27 0.0003
614 OSTEOPENIA 4 0.0003
615 BLOOD URINE PRESENT 5 0.0003
616 HAEMATURIA 9 0.0003
617 MICTURITION URGENCY 3 0.0003
618 VERTIGO 16 0.0003
619 MYOCARDITIS 3 0.0003
620 INJECTION SITE REACTION 18 0.0003
621 MUSCLE SPASMS 48 0.0003
622 NIGHTMARE 9 0.0003
623 AGGRESSION 13 0.0003
624 RASH 113 0.0003
625 HERNIA 5 0.0003
626 CONCUSSION 2 0.0003
627 LOSS OF CONSCIOUSNESS 33 0.0003
628 COVID-19 45 0.0003
629 ADVERSE DRUG REACTION 23 0.0003
630 SPINAL PAIN 3 0.0003
631 SKIN FISSURES 5 0.0003
632 BALANCE DISORDER 22 0.0003
633 ARTERIAL OCCLUSIVE DISEASE 2 0.0003
634 AFFECTIVE DISORDER 2 0.0003
635 ACTIVITIES OF DAILY LIVING IMPAIRED 5 0.0003
636 PROCEDURAL PAIN 7 0.0003
637 HAEMATOCRIT DECREASED 5 0.0003
638 BLOOD ALBUMIN DECREASED 2 0.0003
639 RESPIRATORY TRACT CONGESTION 4 0.0003
640 ULCER 4 0.0003
641 CYSTITIS 8 0.0003
642 OBESITY 4 0.0003
643 HYPERLIPIDAEMIA 3 0.0003
644 GAIT DISTURBANCE 48 0.0003
645 FATIGUE 195 0.0003
646 WRIST FRACTURE 3 0.0003
647 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 12 0.0002
648 BLOOD DISORDER 2 0.0002
649 SPINAL FRACTURE 5 0.0002
650 SPEECH DISORDER 13 0.0002
651 BLOOD POTASSIUM INCREASED 4 0.0002
652 DIARRHOEA 159 0.0002
653 BACK DISORDER 4 0.0002
654 RESPIRATORY DEPRESSION 3 0.0002
655 ABNORMAL FAECES 2 0.0002
656 CARDIOMEGALY 3 0.0002
657 ABASIA 6 0.0002
658 CONDITION AGGRAVATED 73 0.0002
659 PULMONARY HYPERTENSION 5 0.0002
660 BONE PAIN 14 0.0002
661 RENAL IMPAIRMENT 20 0.0002
662 BRAIN OEDEMA 3 0.0002
663 TRANSIENT ISCHAEMIC ATTACK 8 0.0002
664 PYREXIA 82 0.0002
665 MUSCLE ATROPHY 3 0.0002
666 HEMIPARESIS 4 0.0002
667 JOINT INJURY 5 0.0002
668 MYDRIASIS 3 0.0002
669 VISION BLURRED 32 0.0002
670 SKIN ULCER 6 0.0002
671 ASTHENIA 87 0.0002
672 DEVICE DISLOCATION 10 0.0002
673 IMMUNE SYSTEM DISORDER 3 0.0002
674 TOOTH INFECTION 3 0.0002
675 PULMONARY CONGESTION 3 0.0002
676 COLD SWEAT 4 0.0002
677 DRUG INTERACTION 36 0.0002
678 LYMPHOCYTE COUNT DECREASED 4 0.0002
679 HOT FLUSH 17 0.0002
680 ANAEMIA 43 0.0002
681 STEVENS-JOHNSON SYNDROME 5 0.0002
682 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 16 0.0002
683 GENERAL PHYSICAL HEALTH DETERIORATION 26 0.0002
684 DYSPEPSIA 22 0.0002
685 QUALITY OF LIFE DECREASED 3 0.0002
686 RASH PAPULAR 5 0.0002
687 JAUNDICE 6 0.0002
688 SNEEZING 5 0.0002
689 TREMOR 37 0.0002
690 PALPITATIONS 26 0.0002
691 UVEITIS 3 0.0002
692 DRUG TOXICITY 3 0.0002
693 WRONG TECHNIQUE IN DRUG USAGE PROCESS 8 0.0002
694 RHEUMATOID ARTHRITIS 25 0.0002
695 IMPAIRED GASTRIC EMPTYING 3 0.0002
696 HYPERGLYCAEMIA 8 0.0002
697 CATARACT 13 0.0002
698 PRODUCT USE IN UNAPPROVED INDICATION 54 0.0002
699 DIVERTICULITIS 6 0.0002
700 BREAST CANCER STAGE I 2 0.0002
701 POLLAKIURIA 9 0.0002
702 BACTERIAL INFECTION 4 0.0002
703 HAEMOGLOBIN DECREASED 22 0.0002
704 MIDDLE INSOMNIA 4 0.0002
705 TACHYCARDIA 19 0.0002
706 SKIN REACTION 3 0.0002
707 SINUS TACHYCARDIA 3 0.0002
708 GASTRIC ULCER 4 0.0002
709 PROTEINURIA 4 0.0002
710 DISEASE RECURRENCE 10 0.0002
711 HYPERHIDROSIS 27 0.0002
712 PARALYSIS 3 0.0002
713 BLOOD PRESSURE INCREASED 32 0.0002
714 IMPAIRED QUALITY OF LIFE 3 0.0002
715 WHITE BLOOD CELL COUNT INCREASED 8 0.0002
716 BLOOD PRESSURE FLUCTUATION 5 0.0002
717 ACUTE RESPIRATORY FAILURE 4 0.0002
718 ERUCTATION 4 0.0002
719 DEPRESSION 47 0.0002
720 INFLUENZA LIKE ILLNESS 17 0.0002
721 APATHY 3 0.0002
722 INTENTIONAL PRODUCT MISUSE 18 0.0002
723 ATRIAL FIBRILLATION 20 0.0002
724 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 37 0.0002
725 ALOPECIA 40 0.0002
726 PSYCHOTIC DISORDER 6 0.0002
727 LIVER DISORDER 9 0.0002
728 URINARY INCONTINENCE 6 0.0002
729 RENAL INJURY 6 0.0002
730 DYSGEUSIA 15 0.0002
731 CONSTIPATION 44 0.0002
732 DELIRIUM 7 0.0002
733 PULMONARY OEDEMA 9 0.0002
734 GASTROINTESTINAL DISORDER 18 0.0002
735 RESPIRATORY DISORDER 6 0.0002
736 SYNCOPE 20 0.0002
737 TASTE DISORDER 4 0.0002
738 DEVICE FAILURE 3 0.0002
739 BODY TEMPERATURE INCREASED 4 0.0002
740 PHARYNGEAL OEDEMA 3 0.0002
741 DEHYDRATION 26 0.0002
742 DEVICE RELATED INFECTION 3 0.0002
743 THERAPY CESSATION 10 0.0002
744 PRODUCT PREPARATION ERROR 4 0.0002
745 THYROID DISORDER 3 0.0002
746 PERITONITIS 4 0.0002
747 PANIC ATTACK 7 0.0002
748 MATERNAL EXPOSURE DURING PREGNANCY 17 0.0002
749 AGITATION 14 0.0002
750 ANHEDONIA 5 0.0002
751 EMOTIONAL DISTRESS 23 0.0002
752 MOUTH ULCERATION 4 0.0002
753 DYSPHAGIA 18 0.0002
754 ABDOMINAL PAIN UPPER 39 0.0002
755 PNEUMOTHORAX 3 0.0002
756 ABDOMINAL PAIN 44 0.0002
757 HALLUCINATION, AUDITORY 3 0.0002
758 FEELING ABNORMAL 45 0.0002
759 BREAST PAIN 2 0.0002
760 SENSORY DISTURBANCE 3 0.0002
761 FLUSHING 19 0.0002
762 VISUAL IMPAIRMENT 23 0.0002
763 DECREASED ACTIVITY 2 0.0002
764 COLITIS 7 0.0002
765 ALTERED STATE OF CONSCIOUSNESS 4 0.0002
766 INCORRECT PRODUCT ADMINISTRATION DURATION 4 0.0002
767 AMNESIA 12 0.0002
768 BIPOLAR DISORDER 2 0.0002
769 PALLOR 5 0.0002
770 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
771 IRRITABILITY 11 0.0002
772 EYE DISORDER 6 0.0002
773 MANIA 3 0.0002
774 ABDOMINAL DISTENSION 19 0.0002
775 MEMORY IMPAIRMENT 25 0.0002
776 OFF LABEL USE 159 0.0002
777 ABNORMAL DREAMS 5 0.0002
778 ILL-DEFINED DISORDER 11 0.0002
779 PSYCHOMOTOR HYPERACTIVITY 3 0.0002
780 TRANSAMINASES INCREASED 4 0.0002
781 URINARY RETENTION 6 0.0002
782 HEPATOTOXICITY 4 0.0002
783 BLOOD UREA INCREASED 3 0.0002
784 WEIGHT DECREASED 50 0.0002
785 VOMITING 84 0.0002
786 RESPIRATORY FAILURE 13 0.0002
787 PANCREATITIS ACUTE 4 0.0002
788 CANDIDA INFECTION 3 0.0002
789 HEART RATE IRREGULAR 4 0.0002
790 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 3 0.0002
791 PRODUCT DOSE OMISSION IN ERROR 5 0.0002
792 INTERNATIONAL NORMALISED RATIO INCREASED 5 0.0002
793 SUICIDAL IDEATION 16 0.0002
794 HYPERSOMNIA 5 0.0002
795 BLOOD CREATINE PHOSPHOKINASE INCREASED 5 0.0002
796 DYSKINESIA 7 0.0002
797 ANXIETY 49 0.0002
798 BLINDNESS 7 0.0002
799 CAESAREAN SECTION 2 0.0002
800 DEVICE USE ISSUE 3 0.0002
801 AMENORRHOEA 3 0.0002
802 ASCITES 5 0.0002
803 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
804 COVID-19 PNEUMONIA 2 0.0002
805 DEEP VEIN THROMBOSIS 11 0.0002
806 BLOOD CREATININE INCREASED 11 0.0002
807 THIRST 3 0.0002
808 NAUSEA 131 0.0002
809 LACRIMATION INCREASED 5 0.0002
810 PELVIC PAIN 3 0.0002
811 CRYING 6 0.0002
812 MENTAL IMPAIRMENT 4 0.0002
813 PLEURAL EFFUSION 10 0.0002
814 CYTOPENIA 2 0.0002
815 ENCEPHALOPATHY 4 0.0002
816 EMOTIONAL DISORDER 5 0.0002
817 MEDICATION ERROR 9 0.0002
818 CONJUNCTIVITIS 3 0.0002
819 EYE SWELLING 6 0.0002
820 VAGINAL HAEMORRHAGE 7 0.0002
821 HEPATIC STEATOSIS 3 0.0002
822 THINKING ABNORMAL 3 0.0002
823 EXPOSURE DURING PREGNANCY 10 0.0002
824 EPISTAXIS 12 0.0002
825 CARDIAC DISORDER 15 0.0002
826 EYE PAIN 9 0.0002
827 DRUG-INDUCED LIVER INJURY 5 0.0002
828 INTESTINAL OBSTRUCTION 6 0.0002
829 ANGIOEDEMA 7 0.0002
830 HYPOPHAGIA 4 0.0002
831 DEVICE ISSUE 14 0.0002
832 MOVEMENT DISORDER 5 0.0002
833 UNRESPONSIVE TO STIMULI 4 0.0002
834 DIPLOPIA 4 0.0002
835 ORAL HERPES 3 0.0002
836 PSORIASIS 20 0.0002
837 DEAFNESS 4 0.0002
838 KIDNEY INFECTION 3 0.0002
839 CHOLELITHIASIS 5 0.0002
840 TINNITUS 7 0.0002
841 ADVERSE REACTION 2 0.0002
842 THERAPEUTIC RESPONSE SHORTENED 5 0.0002
843 ASPARTATE AMINOTRANSFERASE INCREASED 8 0.0002
844 BLOOD PRESSURE DECREASED 10 0.0002
845 NEOPLASM MALIGNANT 10 0.0001
846 PRODUCT DOSE OMISSION ISSUE 44 0.0001
847 FREQUENT BOWEL MOVEMENTS 4 0.0001
848 BLOOD BILIRUBIN INCREASED 4 0.0001
849 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 30 0.0001
850 THROAT TIGHTNESS 4 0.0001
851 OCULAR HYPERAEMIA 7 0.0001
852 ALANINE AMINOTRANSFERASE INCREASED 9 0.0001
853 PARAESTHESIA 23 0.0001
854 MALAISE 64 0.0001
855 UNEVALUABLE EVENT 11 0.0001
856 TOOTH LOSS 3 0.0001
857 DIABETES MELLITUS 11 0.0001
858 COORDINATION ABNORMAL 2 0.0001
859 THROMBOCYTOPENIA 16 0.0001
860 WEIGHT INCREASED 32 0.0001
861 CARPAL TUNNEL SYNDROME 2 0.0001
862 HYPERKALAEMIA 5 0.0001
863 HYPOXIA 5 0.0001
864 DIALYSIS 2 0.0001
865 PLATELET COUNT DECREASED 15 0.0001
866 INTENTIONAL DOSE OMISSION 4 0.0001
867 DRY EYE 7 0.0001
868 RED BLOOD CELL COUNT DECREASED 4 0.0001
869 CONVULSION 8 0.0001
870 INCORRECT ROUTE OF DRUG ADMINISTRATION 5 0.0001
871 ANGINA PECTORIS 4 0.0001
872 FAECES DISCOLOURED 3 0.0001
873 NEEDLE ISSUE 4 0.0001
874 ACCIDENTAL OVERDOSE 5 0.0001
875 RESTLESSNESS 5 0.0001
876 SURGERY 8 0.0001
877 MELAENA 3 0.0001
878 ACCIDENTAL EXPOSURE TO PRODUCT 14 0.0001
879 DRY SKIN 18 0.0001
880 PREMATURE BABY 4 0.0001
881 DERMATITIS ATOPIC 7 0.0001
882 CORONARY ARTERY DISEASE 4 0.0001
883 SHOCK 3 0.0001
884 DISTURBANCE IN ATTENTION 7 0.0001
885 ANKLE FRACTURE 2 0.0001
886 WHITE BLOOD CELL COUNT DECREASED 14 0.0001
887 DELUSION 2 0.0001
888 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 3 0.0001
889 COGNITIVE DISORDER 6 0.0001
890 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 6 0.0001
891 BASAL CELL CARCINOMA 2 0.0001
892 NERVOUS SYSTEM DISORDER 4 0.0001
893 ARRHYTHMIA 6 0.0001
894 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
895 COMA 6 0.0001
896 MOOD SWINGS 4 0.0001
897 MULTIPLE SCLEROSIS 6 0.0001
898 THROMBOSIS 10 0.0001
899 UNDERDOSE 9 0.0001
900 HERPES ZOSTER 7 0.0001
901 PRODUCT SUBSTITUTION ISSUE 7 0.0001
902 STAPHYLOCOCCAL INFECTION 4 0.0001
903 INJECTION SITE ERYTHEMA 15 0.0001
904 EXTRAPYRAMIDAL DISORDER 3 0.0001
905 CARDIO-RESPIRATORY ARREST 5 0.0001
906 ABDOMINAL PAIN LOWER 3 0.0001
907 CARDIOVASCULAR DISORDER 3 0.0001
908 CEREBROVASCULAR ACCIDENT 20 0.0001
909 DRUG EXPOSURE DURING PREGNANCY 4 0.0001
910 GASTRIC DISORDER 4 0.0001
911 DEVICE DEFECTIVE 2 0.0001
912 MENTAL DISORDER 5 0.0001
913 HAEMORRHAGE 12 0.0001
914 ECZEMA 6 0.0001
915 HEART RATE DECREASED 4 0.0001
916 INCORRECT DOSE ADMINISTERED 26 0.0001
917 CEREBRAL HAEMORRHAGE 4 0.0001
918 PNEUMONITIS 3 0.0001
919 DRUG EFFECT INCOMPLETE 4 0.0001
920 BONE DISORDER 2 0.0001
921 HAEMATOCHEZIA 6 0.0001
922 RENAL DISORDER 5 0.0001
923 TARDIVE DYSKINESIA 3 0.0001
924 BLOOD SODIUM DECREASED 2 0.0001
925 CHOLESTASIS 2 0.0001
926 PANCREATIC CARCINOMA 3 0.0001
927 DYSSTASIA 3 0.0001
928 LEUKOPENIA 5 0.0001
929 CARDIAC FAILURE 8 0.0001
930 EPILEPSY 3 0.0001
931 MALIGNANT NEOPLASM PROGRESSION 10 0.0001
932 RHABDOMYOLYSIS 4 0.0001
933 DERMATITIS 2 0.0001
934 SEIZURE 11 0.0001
935 PULMONARY EMBOLISM 9 0.0001
936 BRADYCARDIA 5 0.0001
937 RENAL FAILURE ACUTE 4 0.0001
938 METABOLIC ACIDOSIS 3 0.0001
939 DISEASE PROGRESSION 11 0.0001
940 DRUG EFFECT DECREASED 5 0.0001
941 OVERDOSE 20 0.0001
942 TREATMENT NONCOMPLIANCE 5 0.0001
943 VISUAL ACUITY REDUCED 3 0.0001
944 VIRAL INFECTION 3 0.0001
945 CARDIAC FAILURE CONGESTIVE 7 0.0001
946 LYMPHADENOPATHY 3 0.0001
947 HOSPITALISATION 13 0.0001
948 BLOOD GLUCOSE DECREASED 4 0.0001
949 DIABETIC KETOACIDOSIS 2 0.0001
950 INJECTION SITE MASS 3 0.0001
951 DYSARTHRIA 3 0.0001
952 DEATH 67 0.0001
953 PLASMA CELL MYELOMA 3 0.0001
954 ABNORMAL BEHAVIOUR 3 0.0001
955 DEVICE DIFFICULT TO USE 5 0.0001
956 INJECTION SITE HAEMORRHAGE 6 0.0001
957 BREAST CANCER 7 0.0001
958 DRUG DEPENDENCE 12 0.0001
959 MYOCARDIAL INFARCTION 13 0.0001
960 EXTRA DOSE ADMINISTERED 3 0.0001
961 DEVICE BREAKAGE 3 0.0001
962 NEUTROPENIA 10 0.0001
963 PANCYTOPENIA 4 0.0001
964 DEMENTIA 2 0.0001
965 THERAPY INTERRUPTED 5 0.0001
966 HYPOACUSIS 3 0.0001
967 EYE IRRITATION 4 0.0001
968 COLITIS ULCERATIVE 3 0.0001
969 DRUG DOSE OMISSION 11 0.0001
970 SUICIDE ATTEMPT 4 0.0001
971 ACNE 5 0.0001
972 INJECTION SITE SWELLING 5 0.0001
973 INJECTION SITE PAIN 20 0.0001
974 BONE DENSITY DECREASED 2 0.0001
975 BLOOD GLUCOSE INCREASED 12 0.0001
976 INTENTIONAL OVERDOSE 4 0.0001
977 HYPOGLYCAEMIA 3 0.0001
978 PRODUCT DOSE OMISSION 4 0.0001
979 CARDIAC ARREST 5 0.0001
980 GASTROINTESTINAL HAEMORRHAGE 5 0.0001
981 ANGER 2 0.0001
982 MULTIPLE SCLEROSIS RELAPSE 4 0.0001
983 DEVICE USE ERROR 2 0.0001
984 DRUG WITHDRAWAL SYNDROME 5 0.0001
985 PANCREATITIS 3 0.0001
986 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
987 DRUG ABUSE 4 0.0000
988 TOXICITY TO VARIOUS AGENTS 8 0.0000
989 DEVICE LEAKAGE 2 0.0000
990 INJECTION SITE PRURITUS 3 0.0000
991 DEVICE MALFUNCTION 3 0.0000
992 DEPENDENCE 2 0.0000
993 COMPLETED SUICIDE 2 0.0000